| Marc S Schumann, DPM | |
|
260 W Sunrise Hwy, Suite 111, Valley Stream, NY 11581-1011 | |
| (516) 791-7668 | |
| (516) 791-0174 |
| Full Name | Marc S Schumann |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 35 Years |
| Location | 260 W Sunrise Hwy, Valley Stream, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972525418 | NPI | - | NPPES |
| 01178954 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | N004692 (New York) | Primary |
| Provider Name | Nassau Health Care Corporation |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1902822992 PECOS PAC ID: 2961315221 Enrollment ID: O20040619000043 |
News Archive
Skin cancer is the most commonly diagnosed cancer in the United States, and melanoma is the most severe type of skin cancer.
Neuroscientists from Higher School of Economics and Charité University Clinic in Berlin have come up with a new multivariate method for predicting behavioral response to a stimulus using information about the phase of preceding neuronal oscillations recorded with EEG.
Watson Pharmaceuticals, Inc. and Gedeon Richter Plc today announced that Watson's subsidiary, Watson Laboratories, Inc. has entered into an exclusive licensing agreement with PregLem, S.A., ("Preglem") the wholly owned subsidiary of Richter, to develop and market Esmya™ (ulipristal acetate) in the U.S. and Canada.
Several blogs recently reported on issues discussed last week during a conference sponsored by Medecins Sans Frontieres (MSF), the Drugs for Neglected Diseases initiative (DNDi), and the Mount Sinai School of Medicine in New York, titled "Lives in the Balance: Delivering Medical Innovations for Neglected Patients and Populations."
› Verified 1 days ago
| Provider Name | Hospitalist Healthcare Services Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1275962011 PECOS PAC ID: 1557599313 Enrollment ID: O20140124001195 |
News Archive
Skin cancer is the most commonly diagnosed cancer in the United States, and melanoma is the most severe type of skin cancer.
Neuroscientists from Higher School of Economics and Charité University Clinic in Berlin have come up with a new multivariate method for predicting behavioral response to a stimulus using information about the phase of preceding neuronal oscillations recorded with EEG.
Watson Pharmaceuticals, Inc. and Gedeon Richter Plc today announced that Watson's subsidiary, Watson Laboratories, Inc. has entered into an exclusive licensing agreement with PregLem, S.A., ("Preglem") the wholly owned subsidiary of Richter, to develop and market Esmya™ (ulipristal acetate) in the U.S. and Canada.
Several blogs recently reported on issues discussed last week during a conference sponsored by Medecins Sans Frontieres (MSF), the Drugs for Neglected Diseases initiative (DNDi), and the Mount Sinai School of Medicine in New York, titled "Lives in the Balance: Delivering Medical Innovations for Neglected Patients and Populations."
› Verified 1 days ago
| Provider Name | Metro Community Health Centers Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1841536554 PECOS PAC ID: 8921227687 Enrollment ID: O20140912000473 |
News Archive
Skin cancer is the most commonly diagnosed cancer in the United States, and melanoma is the most severe type of skin cancer.
Neuroscientists from Higher School of Economics and Charité University Clinic in Berlin have come up with a new multivariate method for predicting behavioral response to a stimulus using information about the phase of preceding neuronal oscillations recorded with EEG.
Watson Pharmaceuticals, Inc. and Gedeon Richter Plc today announced that Watson's subsidiary, Watson Laboratories, Inc. has entered into an exclusive licensing agreement with PregLem, S.A., ("Preglem") the wholly owned subsidiary of Richter, to develop and market Esmya™ (ulipristal acetate) in the U.S. and Canada.
Several blogs recently reported on issues discussed last week during a conference sponsored by Medecins Sans Frontieres (MSF), the Drugs for Neglected Diseases initiative (DNDi), and the Mount Sinai School of Medicine in New York, titled "Lives in the Balance: Delivering Medical Innovations for Neglected Patients and Populations."
› Verified 1 days ago
| Provider Name | Medical Director Services Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1871955807 PECOS PAC ID: 0042501116 Enrollment ID: O20160621000218 |
News Archive
Skin cancer is the most commonly diagnosed cancer in the United States, and melanoma is the most severe type of skin cancer.
Neuroscientists from Higher School of Economics and Charité University Clinic in Berlin have come up with a new multivariate method for predicting behavioral response to a stimulus using information about the phase of preceding neuronal oscillations recorded with EEG.
Watson Pharmaceuticals, Inc. and Gedeon Richter Plc today announced that Watson's subsidiary, Watson Laboratories, Inc. has entered into an exclusive licensing agreement with PregLem, S.A., ("Preglem") the wholly owned subsidiary of Richter, to develop and market Esmya™ (ulipristal acetate) in the U.S. and Canada.
Several blogs recently reported on issues discussed last week during a conference sponsored by Medecins Sans Frontieres (MSF), the Drugs for Neglected Diseases initiative (DNDi), and the Mount Sinai School of Medicine in New York, titled "Lives in the Balance: Delivering Medical Innovations for Neglected Patients and Populations."
› Verified 1 days ago
| Provider Name | New York General Medical Services Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1700315538 PECOS PAC ID: 7810255494 Enrollment ID: O20180103003151 |
News Archive
Skin cancer is the most commonly diagnosed cancer in the United States, and melanoma is the most severe type of skin cancer.
Neuroscientists from Higher School of Economics and Charité University Clinic in Berlin have come up with a new multivariate method for predicting behavioral response to a stimulus using information about the phase of preceding neuronal oscillations recorded with EEG.
Watson Pharmaceuticals, Inc. and Gedeon Richter Plc today announced that Watson's subsidiary, Watson Laboratories, Inc. has entered into an exclusive licensing agreement with PregLem, S.A., ("Preglem") the wholly owned subsidiary of Richter, to develop and market Esmya™ (ulipristal acetate) in the U.S. and Canada.
Several blogs recently reported on issues discussed last week during a conference sponsored by Medecins Sans Frontieres (MSF), the Drugs for Neglected Diseases initiative (DNDi), and the Mount Sinai School of Medicine in New York, titled "Lives in the Balance: Delivering Medical Innovations for Neglected Patients and Populations."
› Verified 1 days ago
| Provider Name | Care Physicians Of Ny Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1558982199 PECOS PAC ID: 3072933738 Enrollment ID: O20201019000937 |
News Archive
Skin cancer is the most commonly diagnosed cancer in the United States, and melanoma is the most severe type of skin cancer.
Neuroscientists from Higher School of Economics and Charité University Clinic in Berlin have come up with a new multivariate method for predicting behavioral response to a stimulus using information about the phase of preceding neuronal oscillations recorded with EEG.
Watson Pharmaceuticals, Inc. and Gedeon Richter Plc today announced that Watson's subsidiary, Watson Laboratories, Inc. has entered into an exclusive licensing agreement with PregLem, S.A., ("Preglem") the wholly owned subsidiary of Richter, to develop and market Esmya™ (ulipristal acetate) in the U.S. and Canada.
Several blogs recently reported on issues discussed last week during a conference sponsored by Medecins Sans Frontieres (MSF), the Drugs for Neglected Diseases initiative (DNDi), and the Mount Sinai School of Medicine in New York, titled "Lives in the Balance: Delivering Medical Innovations for Neglected Patients and Populations."
› Verified 1 days ago
| Provider Name | Nv Pacs 2 Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1427534809 PECOS PAC ID: 0941550578 Enrollment ID: O20210831002021 |
News Archive
Skin cancer is the most commonly diagnosed cancer in the United States, and melanoma is the most severe type of skin cancer.
Neuroscientists from Higher School of Economics and Charité University Clinic in Berlin have come up with a new multivariate method for predicting behavioral response to a stimulus using information about the phase of preceding neuronal oscillations recorded with EEG.
Watson Pharmaceuticals, Inc. and Gedeon Richter Plc today announced that Watson's subsidiary, Watson Laboratories, Inc. has entered into an exclusive licensing agreement with PregLem, S.A., ("Preglem") the wholly owned subsidiary of Richter, to develop and market Esmya™ (ulipristal acetate) in the U.S. and Canada.
Several blogs recently reported on issues discussed last week during a conference sponsored by Medecins Sans Frontieres (MSF), the Drugs for Neglected Diseases initiative (DNDi), and the Mount Sinai School of Medicine in New York, titled "Lives in the Balance: Delivering Medical Innovations for Neglected Patients and Populations."
› Verified 1 days ago
| Provider Name | Patient First Medical Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1255067955 PECOS PAC ID: 0042687006 Enrollment ID: O20221103001230 |
News Archive
Skin cancer is the most commonly diagnosed cancer in the United States, and melanoma is the most severe type of skin cancer.
Neuroscientists from Higher School of Economics and Charité University Clinic in Berlin have come up with a new multivariate method for predicting behavioral response to a stimulus using information about the phase of preceding neuronal oscillations recorded with EEG.
Watson Pharmaceuticals, Inc. and Gedeon Richter Plc today announced that Watson's subsidiary, Watson Laboratories, Inc. has entered into an exclusive licensing agreement with PregLem, S.A., ("Preglem") the wholly owned subsidiary of Richter, to develop and market Esmya™ (ulipristal acetate) in the U.S. and Canada.
Several blogs recently reported on issues discussed last week during a conference sponsored by Medecins Sans Frontieres (MSF), the Drugs for Neglected Diseases initiative (DNDi), and the Mount Sinai School of Medicine in New York, titled "Lives in the Balance: Delivering Medical Innovations for Neglected Patients and Populations."
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marc S Schumann, DPM 260 W Sunrise Hwy, Suite 111, Valley Stream, NY 11581-1011 Ph: (516) 791-7668 | Marc S Schumann, DPM 260 W Sunrise Hwy, Suite 111, Valley Stream, NY 11581-1011 Ph: (516) 791-7668 |
News Archive
Skin cancer is the most commonly diagnosed cancer in the United States, and melanoma is the most severe type of skin cancer.
Neuroscientists from Higher School of Economics and Charité University Clinic in Berlin have come up with a new multivariate method for predicting behavioral response to a stimulus using information about the phase of preceding neuronal oscillations recorded with EEG.
Watson Pharmaceuticals, Inc. and Gedeon Richter Plc today announced that Watson's subsidiary, Watson Laboratories, Inc. has entered into an exclusive licensing agreement with PregLem, S.A., ("Preglem") the wholly owned subsidiary of Richter, to develop and market Esmya™ (ulipristal acetate) in the U.S. and Canada.
Several blogs recently reported on issues discussed last week during a conference sponsored by Medecins Sans Frontieres (MSF), the Drugs for Neglected Diseases initiative (DNDi), and the Mount Sinai School of Medicine in New York, titled "Lives in the Balance: Delivering Medical Innovations for Neglected Patients and Populations."
› Verified 1 days ago
John Haight, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 375 N Central Ave, Valley Stream, NY 11580 Phone: 516-825-4070 Fax: 516-568-2318 | |
Dr. William James Mcshane, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 66 W Merrick Rd, Valley Stream, NY 11580 Phone: 516-825-3880 Fax: 516-599-6257 | |
Brooklyn Podiatry Consultant Pllc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 608 Prescott Pl, Valley Stream, NY 11581 Phone: 718-500-3338 | |
Dr. Errol Lloyd Gindi, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 5 Seaton Gate, Valley Stream, NY 11580 Phone: 516-825-5552 Fax: 516-825-7634 | |
Dr. Michael David Barkin, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 66 W Merrick Rd, Suite 101, Valley Stream, NY 11580 Phone: 516-825-3860 Fax: 516-599-6257 | |
Dr. Sajni Shah, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 66 W Merrick Rd Ste 101, Valley Stream, NY 11580 Phone: 516-825-3860 Fax: 516-599-6257 | |
Mary Ann Bilotti, DPM Podiatrist Medicare: May Accept Medicare Assignments Practice Location: 375 N Central Ave, Valley Stream, NY 11580 Phone: 516-825-4070 Fax: 516-568-2318 |